COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
---|---|---|---|---|
"6,7-Epoxy Docetaxel" | Impurities | CS-T-54108 | 181208-36-6 | Enquire |
1,5-bis(fluorodiisopropylsilyl)pentane | Impurities | CS-O-48693 | Not Available | Enquire |
10- Dec Docetaxel | Impurities | CS-O-14697 | 158810-73-2 | Enquire |
10-Acetyl Docetaxel | Impurities | CS-T-53936 | 125354-16-7 | Enquire |
2- Epi Docetaxel | Impurities | CS-O-31077 | 133577-33-0 | In Stock |
2-Debenzoyl-2-pentenoyl Docetaxel | Impurities | CS-P-07667 | 1412898-66-8 | Enquire |
6-Oxo Docetaxel | Impurities | CS-T-84673 | 1412898-68-0 | Enquire |
Desbenzoyl Docetaxel | Impurities | CS-T-52111 | 160972-48-5 | Enquire |
Docetaxel Crotonaldehyde Analog | Impurities | CS-O-34296 | Not Available | Enquire |
Docetaxel EP Impurity B | Impurities | CS-O-31070 | 167074-97-7 | In Stock |
Docetaxel EP Impurity C | Impurities | CS-O-31100 | 153381-68-1 | In Stock |
Docetaxel Hydrate | Impurities | CS-T-53747 | 700367-34-6 | Enquire |
Docetaxel Impurity 2 | Impurities | CS-P-07664 | 158810-72-1 | Enquire |
Docetaxel Impurity 20 | Impurities | CS-EO-00899 | 1217248-58-2 | Enquire |
Docetaxel Impurity 4 (Oxazolidine 4S | Impurities | CS-P-07665 | 153744-63-9 | Enquire |
Docetaxel Impurity 7 (Na) | Impurities | CS-EO-03493 | 223134-87-0 (Freebase) | Enquire |
Docetaxel Impurity 7 (Oxazolidine 4R | Impurities | CS-P-07666 | 223134-87-0 | Enquire |
Docetaxel Impurity A | Impurities | CS-O-15619 | 1887057-05-7 | Enquire |
Docetaxel Related Compound 1 ((2R, 3S)-3-Phenylisoserine Hyd... | Impurities | CS-P-07662 | 136561-53-0 | Enquire |
Docetaxel Related Compound 2 ((2R, 3S)-Boc-3-Phenylisoserine... | Impurities | CS-P-07663 | 145514-62-1 | In Stock |
Docetaxel side chain impurity | Impurities | CS-O-42772 | 157580-39-7 | Enquire |
N- Formyl Docetaxel | Impurities | CS-O-14698 | Not Available | Enquire |
N-DesBoc Docetaxel | Impurities | CS-T-73745 | 133524-69-3 | Enquire |
N-Des-t-boc-10-deacetyl-7,10-O-bis{[(2,2,2-trichloroethyl)ox... | Impurities | CS-T-52498 | 114915-16-1 | Enquire |